Literature DB >> 15672263

In vivo chondrogenesis of adult bone-marrow-derived autologous mesenchymal stem cells.

Jinwu Chen1, Changyong Wang, Shuanghong Lü, Junzheng Wu, Ximin Guo, Cuimi Duan, Lingzhi Dong, Ying Song, Junchuan Zhang, Dianying Jing, Linbo Wu, Jiandong Ding, Dexue Li.   

Abstract

The purpose of this study has been to investigate the possible effects of the normal joint cavity environment on chondrocytic differentiation of bone-marrow-derived mesenchymal stem cells (MSCs). Autologous bone marrow was aspirated from the iliac crest of male sheep. MSCs were purified, expanded, and labeled with the fluorescent dye PKH26. Labeled MSCs were then grown on a three-dimensional porous scaffold of poly (L-lactic-co-glycolic acid) in vitro and implanted into the joint cavity by a surgical procedure. At 4 or 8 weeks after implantation, the implants were removed for histochemical and immunohistochemical analysis. The cells labeled with red fluorescent PKH26 in the implants expressed type II collagen and synthesized sulfated proteoglycans. However, the osteoblast-specific marker, osteocalcin, was not detected by immunohistochemistry indicating that the implanted MSCs had not differentiated into osteoblasts by being directly exposed to the normal joint cavity. To investigate the possible factors involved in chondrocytic differentiation of MSCs further, we co-cultured sheep MSCs with the main components of the normal joint cavity, viz., synovial fluid or synovial cells, in vitro. After 1 or 2 weeks of co-culture, the MSCs in both co-culture systems expressed markers of chondrogenesis. These results suggest that synovial fluid and synovium from normal joint cavity are important for the chondrocytic differentiation of adult bone-marrow-derived MSCs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15672263     DOI: 10.1007/s00441-004-1025-0

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  31 in total

1.  Evaluating osteochondral defect repair potential of autologous rabbit bone marrow cells on type II collagen scaffold.

Authors:  Wei-Chuan Chen; Chao-Ling Yao; Yu-Hong Wei; I-Ming Chu
Journal:  Cytotechnology       Date:  2010-10-23       Impact factor: 2.058

Review 2.  Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles.

Authors:  Brett Hall; Jennifer Dembinski; A Kate Sasser; Matus Studeny; Michael Andreeff; Frank Marini
Journal:  Int J Hematol       Date:  2007-07       Impact factor: 2.490

3.  Analysis of the material properties of early chondrogenic differentiated adipose-derived stromal cells (ASC) using an in vitro three-dimensional micromass culture system.

Authors:  Yue Xu; Guive Balooch; Michael Chiou; Elena Bekerman; Robert O Ritchie; Michael T Longaker
Journal:  Biochem Biophys Res Commun       Date:  2007-05-25       Impact factor: 3.575

4.  ADSCs differentiated into cardiomyocytes in cardiac microenvironment.

Authors:  Yanxia Zhu; Tianqing Liu; Kedong Song; Ruiming Ning; Xuehu Ma; Zhanfeng Cui
Journal:  Mol Cell Biochem       Date:  2008-12-24       Impact factor: 3.396

5.  In vivo Differentiation Potential of Mesenchymal Stem Cells: Prenatal and Postnatal Model Systems.

Authors:  Courtney Quinn; Alan W Flake
Journal:  Transfus Med Hemother       Date:  2008-05-16       Impact factor: 3.747

6.  PKH26 as a fluorescent label for live human umbilical mesenchymal stem cells.

Authors:  Zhu Shao-Fang; Zhang Hong-Tian; Zhong Zhi-Nian; He Yuan-Li
Journal:  In Vitro Cell Dev Biol Anim       Date:  2011-07-30       Impact factor: 2.416

7.  Oxygen delivery from hyperbarically loaded microtanks extends cell viability in anoxic environments.

Authors:  Colin A Cook; Kathryn C Hahn; Justin B F Morrissette-McAlmon; Warren L Grayson
Journal:  Biomaterials       Date:  2015-03-03       Impact factor: 12.479

Review 8.  Reconstruction of an in vitro niche for the transition from intervertebral disc development to nucleus pulposus regeneration.

Authors:  Mark Shoukry; Jingting Li; Ming Pei
Journal:  Stem Cells Dev       Date:  2013-02-15       Impact factor: 3.272

Review 9.  Applications of neural and mesenchymal stem cells in the treatment of gliomas.

Authors:  Thomas Kosztowski; Hasan A Zaidi; Alfredo Quiñones-Hinojosa
Journal:  Expert Rev Anticancer Ther       Date:  2009-05       Impact factor: 4.512

10.  Cell therapy of congenital corneal diseases with umbilical mesenchymal stem cells: lumican null mice.

Authors:  Hongshan Liu; Jianhua Zhang; Chia-Yang Liu; I-Jong Wang; Martin Sieber; John Chang; James V Jester; Winston W Y Kao
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.